Harrison

Harrison.ai is a global healthcare technology company based in Sydney, Australia, founded in 2018. The company focuses on using artificial intelligence to improve healthcare delivery and access to quality diagnostic care worldwide. Co-founded by brothers Dimitry and Aengus Tran, Harrison.ai aims to enhance clinical diagnosis through innovative AI-driven solutions. The company specializes in developing diagnostic tools for medical imaging and pathology. Its Annalise.ai solutions, created in partnership with I-MED Radiology, support chest X-ray analysis and are utilized by a significant number of radiologists in Australia and other regions. Additionally, Harrison.ai has a joint venture with Sonic Healthcare called Franklin.ai, which focuses on enhancing pathology services. With a global reach, Harrison.ai's products are available in clinics across APAC, Europe, the UK, the Middle East, and the US. Harrison.ai has raised over $112 million in funding and has received recognition for its solutions, including FDA clearance for 12 products. The company's innovations have been shown to significantly improve diagnostic accuracy and cancer detection rates.